Dl-Phenylalanine

Dl-Phenylalanine

SCHEMBL5200313

NC(Cc1ccccc1)C(=O)O.c1ccc2c(c1)C2

nearest known ligand 0.79

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 3/20 0.79
ALPI P09923 1/20 0.79
PKM P14618 1/20 0.79
PTGS1 P23219 1/20 0.79
XIAP P98170 1/20 0.79
HDAC8 Q9BY41 3/20 0.59
SLC1A3 P43003 2/20 0.57
SLC1A2 P43004 2/20 0.57
SLC1A1 P43005 2/20 0.57
SLC15A1 P46059 1/20 0.57
LTA4H P09960 1/20 0.54
HSD17B10 Q99714 1/20 0.51
GRIA2 P42262 1/20 0.50
CYP1A2 P05177 1/20 0.50
NOS3 P29474 1/20 0.49
NOS1 P29475 1/20 0.49
NOS2 P35228 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenylalanine SCHEMBL7741736 1.00 SLC7A5 (0.79) SLC7A5ALPIPKMPTGS1XIAP
Dl-Phenylalanine SCHEMBL7321619 0.98 SLC7A5 (0.76) SLC7A5ALPIPKMPTGS1XIAP
Tyrosine SCHEMBL2311858 0.90 SLC7A5 (0.75) SLC7A5ALPIPKMPTGS1XIAP
Tyrosine SCHEMBL1798938 0.90 SLC7A5 (0.75) SLC7A5ALPIPKMPTGS1XIAP
Tyrosine SCHEMBL6585990 0.90 SLC7A5 (0.75) SLC7A5ALPIPKMPTGS1XIAP
Tyrosine SCHEMBL4757537 0.89 SLC7A5 (0.73) SLC7A5ALPIPKMPTGS1XIAP
Tyrosine SCHEMBL6065563 0.89 SLC7A5 (0.73) SLC7A5ALPIPKMPTGS1XIAP
SCHEMBL23159186 0.89 SLC7A5 (1.00) SLC7A5ALPIPKMPTGS1XIAP
Phenylalanine SCHEMBL8119 0.89 SLC7A5 (1.00) SLC7A5ALPIPKMPTGS1XIAP
Dl-Phenylalanine SCHEMBL8118 0.89 SLC7A5 (1.00) SLC7A5ALPIPKMPTGS1XIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262269-B2 Method for screening combinational bead library; ligands for cancer cells THE REGENTS OF UNIVERSITY OF CALIFORNIA (US) 2007-08-28 US disclosed
WO-2005045430-A1 SCREENING COMBINATORIAL BEAD LIBRARIES FOR CANCER LIGANDS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2005-05-19 WO disclosed
US-20040096906-A1 Method for screening combinatorial bead library; ligands for cancer cells NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2004-05-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040096906-A1 Method for screening combinatorial bead library; ligands for cancer cells EPCAM, MKI67, FGFR3 SLC7A5 3366/4885ALPI 2919/4885PKM 4331/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.